Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Stock (NASDAQ: IVVD) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range1.420 - 4.890 | Open / Close- / - | Float / Outstanding17.528M / 108.982M |
Vol / Avg.0 / 307.811K | Mkt Cap248.480M | P/E- | 50d Avg. Price1.960 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float17.528M | EPS-0.080 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-29 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | -0.420 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Invivyd (NASDAQ: IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Invivyd (NASDAQ: IVVD) was reported by Morgan Stanley on Tuesday, January 24, 2023. The analyst firm set a price target for 2.00 expecting IVVD to fall to within 12 months (a possible -12.28% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Invivyd (NASDAQ: IVVD) is $2.28 last updated February 2, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Invivyd.
Invivyd’s Q4 earnings are confirmed for Wednesday, March 29, 2023.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.